Welcome to the End-of-Life Resources page; a library of information meant to assist physicians, caregivers, and patients find the information they need to better carry out end-of-life care. Can't find what you're looking for? Check back in soon becuse we are adding resources daily to continue populating the end-of-life resource categories.
You may use the categories below to browse topics and resources or use the "Search EOLR" function on the left sidebar.
Background: This Fast Fact discusses treating pain in patients using buprenorphine for opioid addiction. Buprenorphine is a mixed opioid agonist/antagonist, available in the United States in the sublingual form as ‘Subutex,’ and formulated with naloxone as ‘Suboxone.’ It is approved for treatment of opioid addiction in the US; such use is restricted to qualified physicians who have received training and a waiver to practice medication-assisted opioid addiction therapy. Over the last seven years, over 10,000 physicians have been approved to use buprenorphine, with 2,103,000 prescriptions filled in 2007. Given this, clinicians are likely to encounter patients on buprenorphine therapy who also require treatment for pain.
Subscribe to the Newsletter